itay: sure. we like the aussie dollar, where we think, again, you benefit from cyclical recovery, asia, much betterving a prognosis, handling the virus situation much better in australia, and doing quite well, and you have this sort of terminus of monetary easing which is quite likely in all the and new zealand. the aussie dollar has quite a lot going for it, so we are quite bullish on ozzie. the other thing we talk about is sterling. and, again, the binary deal/no deal question. but if you are like me, looking at a last-minute deal, u.k. assets, you know, very cheap on a global basis. a lot of investors are waiting to buy into the u.k. that could be a trade that could move quite a lot. francine: itay, what do you do with turkish lira? i have to ask you about it, because, frankly, you know, the last week was dominated by u.s. politics and what is going on with the central bank. itay: turkey has been a very challenging situation, both for investors and domestically. at the moment, we have a bit of

the eu ss itay will order up to 300 million doses.h many countrie ls inunockdo, the eris anis urgency to meet te pandemicoon. s the thoughthatt there will be a vaccinin te he first months of 2021 is a 20ght at the end of the nneltu. for st pmoeople, the new vaccine n't come sooenn ough. brent: f more tonight, i am joedin by the puty director of the stitute of a real edgy -- virology here. cine is that thiats vac ing goto be two injeconsti and we stillon' 't know how long the immuni wiltyl last. what do you know about that tonight? >> first of f a, i woul say as expressed earlier, tshi vaccine is a silrve lining on thein zorin. zoit i a positive signal and it is verync eouraging. after all, it is se,ec sure,e, r. s es about 90% efficacy. it is ao the first vacce inof its kin tt hahas been generated odafter all it is a vy goer thing the science is able to generate those vaccines inuc sh a short time. qubuthere are sll otinpe oti esontiqus. ereth areav c. he t io basically is thatangeusro d for peopl conserg idin'we do't kn thehe lo-term